RecruitingNCT06601153

Health Improvements by Understanding the Determinants of Residual Risk in Coronary Artery Disease and New Targets for Prevention and Treatment

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondazione Toscana Gabriele Monasterio
Principal Investigator
Danilo Neglia, MD, PhD
Fondazione Toscana Gabriele Monasterio
Intervention
Cardiac CT(diagnostic_test)
Enrollment
961 target
Eligibility
40-75 years · All sexes
Timeline
2023 – 2025

Study locations (2)

Collaborators

CNR Institute of Clinical Physiology, Pisa, Italy · IRCCS SYNLAB SDN, Naples, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06601153 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials